Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 9/20/24 → 9/20/26 |
Funding
- Merck Sharp & Dohme Corporation: $2.00
WCG-25-LUN115I-MSD-PMC: Substudy 01I: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC)
- Arnold, Susanne M (PI)